In vivo uptake of an experimental microencapsulated diphtheria vaccine following sub-cutaneous immunisation

Vaccine

Volumn 22, Issue 19, 2004, Pages 2430-2437

  Peyre, Marisa ^a   Fleck, Roland ^a   Hockley, David ^a   Gander, Bruno ^b   Sesardic, Dorothea ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^b ETH ZURICH   (Switzerland)

Author keywords

Antigen presenting cells; Microspheres; Sub cutaneous immunisation

Indexed keywords

DIPHTHERIA VACCINE; FLUORESCENT DYE; MICROSPHERE; POLYGLACTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; CELL TYPE; CONFERENCE PAPER; CONTROLLED STUDY; DENDRITIC CELL; DIPHTHERIA; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; LYMPHOID TISSUE; MACROPHAGE; MESENTERY LYMPH NODE; MICROENCAPSULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; STATISTICAL SIGNIFICANCE;

ANIMALS; ANTIGEN-PRESENTING CELLS; DIPHTHERIA TOXOID; DRUG DELIVERY SYSTEMS; IMMUNIZATION; INJECTIONS, SUBCUTANEOUS; LACTIC ACID; MICE; MICE, INBRED BALB C; MICROSPHERES; PARTICLE SIZE; POLYGLYCOLIC ACID; POLYMERS; VACCINES, SYNTHETIC;

EID: 2942618481     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2003.11.068     Document Type: Conference Paper

References (23)

1. Aguado M.T. Future approaches to vaccine development: single dose vaccines using controlled-release delivery systems. Vaccine. 11(5):1993;596-597
2. Johansen P., Men Y., Merkle H.P., Gander B. Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination. Eur. J. Pharm. Biopharm. 50(1):2000;129-146
3. Gupta R.K., Singh M., O'Hagan D.T. Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines. Adv. Drug Deliv. Rev. 32(3):1998;225-246
4. Peyre M., Sesardic D., Merkle H.P., Gander B., Johansen P. An experimental divalent vaccine based on biodegradable microspheres induces protective immunity against tetanus and diphtheria. J Pharm Sci. 92(5):2003;957-966
5. Walter E., Dreher D., Kok M., Thiele L., Kiama S.G., Gehr P., et al. Hydrophilic poly(DL-lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells. J. Control Release. 76(1-2):2001;149-168
6. Eyles J.E., Williamson E.D., Alpar H.O. Immunological responses to nasal delivery of free and encapsulated tetanus toxoid: studies on the effect of vehicle volume. Int. J. Pharm. 189(1):1999;75-79
7. 14C -labelled tetanus toxoid Vaccine. 14(15):1996;1412-1416
8. Johansen P., Moon L., Tamber H., Merkle H.P., Gander B., Sesardic D. Immunogenicity of single-dose diphtheria vaccines based on PLA/PLGA microspheres in guinea pigs. Vaccine. 18(3-4):1999;209-215
9. Schijns V.E. Mechanisms of vaccine adjuvant activity: initiation and regulation of immune responses by vaccine adjuvants. Vaccine. 21(9-10):2003;829-831
10. Lomotan E.A., Brown K.A., Speaker T.J., Offita P.A. Aqueous-based microcapsules are detected primarily in gut-associated dendritic cells after oral inoculation of mice. Vaccine. 15(17-18):1997;1959-1962
11. Damge C., Aprahamian M., Marchais H., Benoit J.P., Pinget M. Intestinal absorption of PLAGA microspheres in the rat. J. Anat. 189(Pt 3):1996;491-501
12. Eyles J.E., Bramwell V.W., Williamson E.D., Alpar H.O. Microsphere translocation and immunopotentiation in systemic tissues following intranasal administration. Vaccine. 19(32):2001;4732-4742
13. Gupta RK, Rost BE, Relyveld E, Siber GR. Adjuvant properties of aluminium and calcium compounds. In: Powell MF, Newman MJ, editors. Vaccine Design: the Subunit and Adjuvant Approach. New York; 1995. p. 229-48.
14. Zinkernagel M., Ehl S., Aichele P., Oehen S., Kundig T., Hengartner H. Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity. Immunol Rev. 156:1997;199-209
15. Rimaniol A, Gras G, Verdier F, Capel F, Grigoriev V, Porcheray F, et al. Aluminium hydroxide adjuvant induces macrophage differentiation towards a specialized antigen-presenting cell type. In: Proceedings of the Modern Vaccines Adjuvants and Delivery Systems meeting (MVADS), 2003 [abstract].
16. Johansen P., Merkle H.P., Gander B. Physico-chemical and antigenic properties of tetanus and diphtheria toxoids and steps towards improved stability. Biochim. Biophys. Acta. 1425(2):1998;425-436
17. Xing D.K.L., McLellan K., Corbel M.J., Sesardic D. Estimation of antigenic tetanus extracted from biodegradable microspheres. Biologicals. 24:1996;57-65
18. Boehm G., Peyre M., Sesardic D., Huskisson R.J., Mawas F., Douglas A., et al. On technological and immunological benefits of multivalent single-injection microsphere vaccines. Pharm. Res. 19(9):2002;1330-1336
19. O'Hagan D.T., Singh M. Microparticles as vaccine adjuvants and delivery systems. Expert Rev. Vaccines. 2(2):2003;269-283
20. Tabata Y., Inoue Y., Ikada Y. Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres. Vaccine. 14(17-18):1996;1677-1685
21. Newman K.D., Elamanchili P., Kwon G.S., Samuel J. Uptake of poly(DL-latic-co-glycolic acid) microspheres by antigen-presenting cell in vivo. J. Biomed. Mater. Res. 60(3):2002;480-486
22. Knight S.C., Burke F., Bedford P.A. Interactions between dendritic cells. Adv. Exp. Med. Biol. 495:2001;103-109
23. Men Y, Audran R, Merkle HP, Gander B, Corradin G. Immunological responses with biodegradable polymer microspheres. In: Gander B, Merkle HP, Corradin G, editors. Antigen Delivery Systems, Immunological and Technological Issues. Harwood Academic; 1997. p. 191-205.